Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Year: 2018
Type: review
Source: Kidney International
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, renal protection, type 2 diabetes, diabetic nephropathy, cardiovascular risk reduction, empagliflozin, canagliflozin, albuminuria, renal hyperfiltration, major adverse cardiovascular events, heart failure hospitalization, chronic kidney disease, EMPA-REG OUTCOME trial, CANVAS trial
Open Access status: bronze
OpenAlex ID: W2800723402
